Skip to main content

COVID-19 and impact on peer review

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call for papers: Targeting cancer evolution in the clinic

The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.

Cord blood methylome in newborns and autism

Janine LaSalle and colleagues study the cord blood methylome in a high-familial risk cohort of autism spectrum disorder and identify a methylation signature at birth.

Special issue: Translating the microbiome

Our special issue on ‘Translating the microbiome in health and disease’, guest edited by Ramnik Xavier has launched. Check out new content added over the next months.

Best practices for variant calling

Daniel Koboldt discusses current best practices for variant calling in clinical sequencing studies, focusing on inherited disorders and cancer somatic mutation detection.

Reviews, Research Highlights and Commentaries

Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:

Reviews

Research Highlights

Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)

Articles

Focus: Immunology in Health and Disease

Read the latest papers on immunology across BMC flagship journals.

Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection
Daniel M. Muema​​​​​​​ et al.

Published in BMC Medicine 25 March 2020

The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology​​​​​​​
Shashuang Zhang​​​​​​​​​​​​​​ et al.

Published in BMC Biology 17 March 2020

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma​​​​​​​
Markus W. Löffler​​​​​​​​​​​​​​ et al.

Published in Genome Medicine 30 April 2019

Host-associated microbiomes are predicted by immune system complexity and climate​​​​​​​
Douglas C. Woodhams et al.

Published in Genome Biology 03 February 2020

Aims and scope

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries. 

Article collections

Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler

Collection
A decade of Genome Medicine

Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda

Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal

See all article collections

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

  • Editorial Board
  • Editorial Team
  • Sign up for article alerts and news from this journal
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.